Scope of this review
This review concerns infinitenova.org and the investment offer associated with that domain. It focuses on a current Dutch regulatory warning rather than on unverified accounts of individual users.
What the AFM warning establishes
The Netherlands Authority for the Financial Markets (AFM) published a warning about Infinitenova on 29 September 2026. The authority identifies infinitenova.org and describes the operation as a suspected boiler room. It says the business has no AFM licence and no European passport allowing it to provide financial services in the Netherlands.
A boiler-room warning is especially relevant when an offer reaches you by direct contact or pressures you to act quickly. The AFM's finding does not replace a jurisdiction-specific licence check, but it is a clear reason to pause the proposed investment and verify every detail independently.
Offers, representatives and payment instructions
The important question is not whether a representative can describe a product convincingly; it is whether the named company is authorised to make that offer to you. Ask for the contracting entity, licence number, product disclosure and a written explanation of where client money would be held. Check the entity in the appropriate public register rather than using a link supplied by the caller or website.
If a payment request changes bank account, beneficiary or cryptocurrency wallet after an account is opened, stop and obtain an explanation in writing. A change in payment details should be checked independently before any funds move.
What you should check before you act
- Read the AFM's 29 September 2026 warning for the exact domain and contact details.
- Check the proposed company and licence in the regulator's own register for your country.
- Save messages, call records, account pages and payment instructions.
- Do not use a recovery service or make an additional payment simply because someone says it is needed to release funds.
This article is general research, not financial, legal or investment advice.